Skip to main content
ARX
NYSE Finance

Thoma Bravo to Acquire Accelerant for $20.25/Share in Cash, a 49% Premium

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Positive
Importance info
9
Price
$19.72
Mkt Cap
$2.97B
52W Low
$9.18
52W High
$30.475
52W Position info
115% above low
Off High info
35% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ARX has more than doubled off its 52-week low of $9.18.

Summary

Accelerant Holdings agreed to be acquired by Thoma Bravo for $20.25 per share in cash, a 49% premium, valuing the company at over $4 billion. The deal is expected to close in the first half of 2027.


Key Events · M&A and Partnerships · ARX

  • Definitive Merger Agreement with Thoma Bravo

    Accelerant entered into a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction with an enterprise value of more than $4 billion.

  • Cash Consideration of $20.25 Per Share

    Class A and Class B shareholders will receive $20.25 per share in cash, representing a 49% premium to the August 12, 2026 closing price.

  • Strong Voting Support and No Financing Condition

    Altamont Capital Partners, holding approximately 82% of outstanding voting rights, has agreed to vote in favor. Thoma Bravo has provided an equity commitment, so the deal is not subject to a financing condition.

  • Expected Closing in First Half of 2027

    The transaction is subject to shareholder approval and regulatory approvals, with a 6% per annum ticking fee if closing is delayed by certain pending insurance regulatory approvals.


Analysis · ARX · Finance

Accelerant Holdings has agreed to be acquired by Thoma Bravo in an all-cash deal valuing the company at over $4 billion. Shareholders will receive $20.25 per share, a 49% premium to the last closing price. The transaction is backed by an 82% voting commitment from Altamont Capital Partners and is not subject to a financing condition. The deal is expected to close in the first half of 2027, subject to shareholder and regulatory approvals. The company also reported strong Q2 results, with adjusted EBITDA up 46% year-over-year, but canceled its earnings call and withdrew guidance due to the pending transaction.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 40.2% of the 326 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARX was trading at $19.72 on NYSE in the Finance sector, with a market capitalization of approximately $3B. The 52-week trading range was $9.18 to $30.48. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARX - Latest Insights

ARX
Aug 13, 2026, 9:15 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $19.49
Real-time Price: $19.73 info
Change: +$0.240 (+1%) info
Market Cap: $4.285B info
ARX
Aug 13, 2026, 9:14 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $19.49
Real-time Price: $19.73 info
Change: +$0.240 (+1%) info
Market Cap: $4.285B info
ARX
Aug 13, 2026, 12:42 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $19.54
Real-time Price: $19.73 info
Change: +$0.195 (+1.00%) info
Market Cap: $4.285B info
ARX
Aug 13, 2026, 7:59 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $19.74
Real-time Price: $19.73 info
Change: -$0.0100 (-0.05%) info
Market Cap: $4.285B info
ARX
Aug 13, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $12.91
Real-time Price: $19.73 info
Change: +$6.82 (+53%) info
Market Cap: $4.285B info